GSK Merger is helping HUL ‘s top line, but earnings before tax are down 6 percent in Q1.


Hindustan Unilever (HUL), the nation’s largest shopper items firm, on Tuesday reported a combined set of numbers for the quarter ended June 30, 2020 (Q1), aided partly by its merger with GSK Client on April 1.

Whereas revenue earlier than tax (PBT) for the interval fell 6 per cent year-on-year to Rs 2,411 crore, revenue-wise HUL reported a 4.Four per cent year-on-year enhance to Rs 10,560 crore, due to the merger of GSK Client vitamin manufacturers with the businesses. Income was forward of a Bloomberg consensus estimate of Rs 9,880 crore for the interval. GSK Client’s vitamin portfolio contains Horlicks, Increase, Maltova, and Viva.

Excluding the GSK enterprise, general income declined 7 per cent within the quarter, Srinivas Phatak, chief monetary officer, HUL, mentioned in a digital press meet, indicating the extent of the harm to enterprise as a result of pandemic and nationwide lockdown. The corporate declared a particular dividend of Rs 9.50 per share for the 2020-21 monetary 12 months. Analysts estimate quantity decline for the quarter at eight per cent in Q1, which, they are saying, is healthier than road estimates of a 11-13 per cent quantity decline for the interval.

Within the March quarter, HUL had reported a 7 per cent quantity decline, greater than the Four per cent fall throughout the demonetisation quarter (October-December 2016).

ALSO READ: Khaitans more likely to be part of fingers with Burmans to run Eveready Industries

Web revenue rose 7.2 per cent YoY to Rs 1,881 crore, which compares favourably with the Rs 1,722-crore consensus estimate of analysts tracked by Bloomberg.

Working revenue, nonetheless, fell 0.1 per cent to Rs 2,644 crore in Q1, whereas working margins narrowed to 25 per cent from 26.2 per cent a 12 months in the past. “The detrimental impression of opposed combine and better Covid-19-related prices have been deftly managed by dialling up financial savings and unlocking synergies of the GSK Client merger, enabling us to maintain wholesome margins,” Phatak mentioned.


Whereas rural areas have proven an uptick in gross sales , Sanjiv Mehta, chairman and managing director, HUL, declined to present an outlook for the long run, saying he’d fairly look forward to the September quarter to present an evaluation of demand. HUL will get 40 per cent of its gross sales in rural areas.

“We’re happy with what the federal government is doing to enhance demand, particularly, in rural areas. Nevertheless, uncertainty stays, which can final until a vaccine is discovered. If supply-side disruptions ease, the September quarter ought to give us a very good image of underlying demand,” he mentioned.

Analysts say HUL’s enterprise stays resilient, provided that 80 per cent of its portfolio is concentrated on well being, hygiene, and vitamin, 15 per cent is discretionary in nature, and 5 per cent is concentrated on out-of-home consumption.

“80 per cent of HUL’s enterprise registered a progress fee of 6 per cent in April-June,” mentioned Kaustubh Pawaskar, affiliate vice-president (analysis), Sharekhan. “The vitamin enterprise, together with GSK Client’s merchandise, registered 5 per cent progress, whereas the discretionary portfolio, together with skincare, deos and color cosmetics, and out-of-home consumption, which incorporates ice lotions, declined 45 per cent and 70 per cent, respectively,” he mentioned.